Ultra-Low-Priced Lithium Stock Offers Unlimited Upside in Global EV Boom

From Resource Stock Digest | Ad

Lithium batteries are supplying our planet with clean reliable energy. EVs, laptops, cell phones...you name it. The Smart Money is going into the future suppliers of lithium like this US$0.15 stock that just secured a game-changing lithium asset.

Details Here.

ESPR Insider Trading (Esperion Therapeutics)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.30%

Insider Buying (Last 12 Months): $4,074,000.00

Insider Selling (Last 12 Months): $0.00

Esperion Therapeutics Insider Trading History Chart

Esperion Therapeutics Share Price & Price History

^$25.74

▼ -0.63 (-2.39%)

As of 06/14/2021 01:00 AM ET

Days: 30 | 90 | 365

Could This Be the Biggest Gold Haul in Years?

From Resource Stock Digest | Ad

Mining dream-team confirms multiple high-grade gold discoveries in two ultra-rich mineral belts. Temporarily undiscovered below US$0.25 per share, it’s one of those rare opportunities where the next drill hole could mean 5X or even 10X gains.

Click here for details...

Esperion Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/19/2021	Target N V Biotech	Major Shareholder	Buy	200,000	$20.37	$4,074,000.00	4,377,964
3/11/2020	Timothy M Mayleben	CEO	Buy	2,500	$43.00	$107,500.00	111,998
2/28/2020	Timothy M Mayleben	CEO	Buy	5,000	$49.00	$245,000.00	109,498
1/23/2020	Target N V Biotech	Major Shareholder	Buy	20,000	$51.84	$1,036,800.00	3,747,964
11/6/2019	Target N V Biotech	Major Shareholder	Buy	75,000	$37.30	$2,797,500.00	3,727,964
11/6/2019	Timothy M Mayleben	CEO	Buy	5,000	$36.98	$184,900.00	83,663
9/6/2019	Timothy M Mayleben	CEO	Buy	2,500	$35.25	$88,125.00	76,015
9/4/2019	Target N V Biotech	Major Shareholder	Buy	80,000	$33.78	$2,702,400.00	3,652,964
9/4/2019	Timothy M Mayleben	CEO	Buy	5,000	$34.20	$171,000.00	76,015
8/1/2019	Timothy M Mayleben	CEO	Buy	5,000	$39.56	$197,800.00	71,163
7/23/2019	Target N V Biotech	Major Shareholder	Buy	50,000	$42.65	$2,132,500.00	3,572,964
6/28/2019	Timothy M Mayleben	CEO	Buy	5,000	$46.00	$230,000.00	66,163
4/3/2019	Richard Bartram	CFO	Sell	8,000	$42.88	$343,040.00
3/29/2019	Timothy M Mayleben	CEO	Buy	5,000	$40.00	$200,000.00	61,163
3/20/2019	Timothy M Mayleben	CEO	Buy	5,000	$43.48	$217,400.00	56,163
3/19/2019	Nicole Vitullo	Director	Sell	15,329	$44.73	$685,666.17	8,319
3/14/2019	Target N V Biotech	Major Shareholder	Buy	50,000	$49.89	$2,494,500.00	3,522,964
3/14/2019	Timothy M Mayleben	CEO	Buy	5,000	$48.73	$243,650.00	51,163
3/12/2019	Roger S Newton	Director	Sell	25,000	$50.06	$1,251,500.00	548,726
1/4/2019	Target N V Biotech	Major Shareholder	Buy	80,000	$41.29	$3,303,200.00	3,472,964
12/24/2018	Target N V Biotech	Major Shareholder	Buy	50,000	$39.91	$1,995,500.00	3,392,964
12/17/2018	Target N V Biotech	Major Shareholder	Buy	60,000	$47.73	$2,863,800.00	3,342,964
11/5/2018	Boxer Capital, Llc	Major Shareholder	Sell	100,000	$56.38	$5,638,000.00
11/2/2018	Boxer Capital, Llc	Major Shareholder	Sell	40,000	$55.21	$2,208,400.00
11/2/2018	Roger S Newton	Director	Sell	2,827	$50.07	$141,547.89	573,953
10/18/2018	Roger S Newton	Director	Sell	100	$50.00	$5,000.00	589,326
10/16/2018	Roger S Newton	Director	Sell	9,400	$50.01	$470,094.00	589,326
8/27/2018	Roger S Newton	Director	Sell	17,700	$51.05	$903,585.00	615,726
8/17/2018	Roger S Newton	Director	Sell	7,300	$50.06	$365,438.00	616,426
8/3/2018	Target N V Biotech	Major Shareholder	Buy	50,000	$46.14	$2,307,000.00	3,282,964
7/12/2018	Target N V Biotech	Major Shareholder	Buy	50,000	$41.77	$2,088,500.00	3,232,964
6/29/2018	Target N V Biotech	Major Shareholder	Buy	50,000	$39.48	$1,974,000.00	3,182,964
6/21/2018	Target N V Biotech	Major Shareholder	Buy	60,000	$38.57	$2,314,200.00	3,132,964

SEC Filings (Institutional Ownership Changes) for Esperion Therapeutics (NASDAQ:ESPR)

99.89% of Esperion Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Esperion Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/19/2021	Diametric Capital LP	8,902	$0.25M	0.2%	N/A	0.032%
5/19/2021	Squarepoint Ops LLC	19,545	$0.55M	0.0%	+29.4%	0.069%
5/18/2021	Point72 Asset Management L.P.	648,200	$18.18M	0.1%	N/A	2.299%
5/18/2021	State of Wisconsin Investment Board	34,800	$0.98M	0.0%	-5.9%	0.123%
5/18/2021	Morgan Stanley	107,702	$3.02M	0.0%	-54.2%	0.382%
5/18/2021	Tudor Investment Corp Et Al	29,334	$0.82M	0.0%	-24.4%	0.104%
5/18/2021	Cubist Systematic Strategies LLC	41,129	$1.15M	0.0%	+27.6%	0.146%
5/18/2021	Man Group plc	28,026	$0.79M	0.0%	-25.4%	0.099%
5/18/2021	Pentwater Capital Management LP	607,580	$17.04M	0.2%	+22.1%	2.155%
5/17/2021	Endurant Capital Management LP	55,540	$1.56M	0.4%	-73.2%	0.197%
5/17/2021	PDT Partners LLC	16,778	$0.47M	0.0%	N/A	0.060%
5/17/2021	Virtus ETF Advisers LLC	21,157	$0.59M	0.3%	+2.8%	0.075%
5/17/2021	Royal Bank of Canada	7,451	$0.21M	0.0%	+83.5%	0.026%
5/17/2021	Credit Agricole S A	4,900	$0.14M	0.0%	N/A	0.017%
5/17/2021	Price T Rowe Associates Inc. MD	17,042	$0.48M	0.0%	+69.3%	0.060%
5/17/2021	Nomura Holdings Inc.	71,527	$2M	0.0%	-75.2%	0.254%
5/17/2021	Nuveen Asset Management LLC	214,134	$6.01M	0.0%	+81.1%	0.760%
5/17/2021	Goldman Sachs Group Inc.	17,718	$0.50M	0.0%	-82.0%	0.063%
5/14/2021	Weiss Multi Strategy Advisers LLC	12,493	$0.35M	0.0%	-10.9%	0.044%
5/14/2021	UBS Asset Management Americas Inc.	27,236	$0.76M	0.0%	+18.4%	0.097%
5/14/2021	Stifel Financial Corp	26,519	$0.74M	0.0%	+5.1%	0.094%
5/14/2021	Credit Suisse AG	116,133	$3.26M	0.0%	+40.9%	0.412%
5/13/2021	Trexquant Investment LP	15,807	$0.44M	0.0%	N/A	0.056%
5/13/2021	SG Americas Securities LLC	16,266	$0.46M	0.0%	+4.6%	0.058%
5/13/2021	Barclays PLC	38,020	$1.07M	0.0%	-31.6%	0.135%
5/13/2021	Mutual of America Capital Management LLC	76,831	$2.16M	0.0%	-5.2%	0.273%
5/13/2021	Bank of New York Mellon Corp	101,292	$2.84M	0.0%	-14.2%	0.359%
5/13/2021	Citigroup Inc.	165,031	$4.63M	0.0%	+405.3%	0.585%
5/13/2021	Bank of Montreal Can	1,185	$33K	0.0%	-73.1%	0.004%
5/13/2021	Platinum Investment Management Ltd.	1,600,613	$44.90M	1.0%	+2.4%	5.678%
5/12/2021	Northern Trust Corp	304,925	$8.55M	0.0%	-6.2%	1.082%
5/12/2021	Geode Capital Management LLC	448,663	$12.58M	0.0%	+10.0%	1.591%
5/12/2021	Pinnacle Associates Ltd.	267,011	$7.49M	0.1%	-9.4%	0.947%
5/12/2021	DCF Advisers LLC	17,286	$0.49M	0.2%	-55.1%	0.061%
5/12/2021	JPMorgan Chase & Co.	124,787	$3.50M	0.0%	-5.0%	0.443%
5/12/2021	E Fund Management Co. Ltd.	4,570	$0.13M	0.0%	N/A	0.016%
5/12/2021	UBS Group AG	66,575	$1.87M	0.0%	+366.2%	0.236%
5/12/2021	Bellevue Group AG	3,989,164	$111.90M	1.2%	-22.4%	14.150%
5/10/2021	Russell Investments Group Ltd.	31,565	$0.88M	0.0%	-28.4%	0.112%
5/10/2021	Resources Investment Advisors LLC.	23,570	$0.66M	0.0%	+104.1%	0.084%
5/10/2021	Wasatch Advisors Inc.	4,118,085	$115.51M	0.5%	+3.0%	14.607%
5/10/2021	State Board of Administration of Florida Retirement System	12,410	$0.35M	0.0%	-10.9%	0.044%
5/10/2021	GAM Holding AG	70,700	$1.98M	0.1%	N/A	0.251%
5/10/2021	Rafferty Asset Management LLC	109,815	$3.08M	0.0%	+267.8%	0.390%
5/7/2021	BlackRock Inc.	2,146,396	$60.21M	0.0%	+4.0%	7.613%
5/7/2021	Swiss National Bank	60,500	$1.70M	0.0%	+1.7%	0.215%
5/7/2021	The PNC Financial Services Group Inc.	6,906	$0.19M	0.0%	+1,264.8%	0.025%
5/6/2021	Arizona State Retirement System	7,709	$0.22M	0.0%	N/A	0.027%
5/6/2021	Rhumbline Advisers	32,071	$0.90M	0.0%	-8.2%	0.114%
5/6/2021	Alliancebernstein L.P.	23,770	$0.67M	0.0%	-21.0%	0.084%
5/5/2021	EMC Capital Management	27,995	$0.79M	0.6%	+97.2%	0.099%
5/5/2021	Hamilton Lane Advisors LLC	21,253	$0.60M	0.2%	-54.0%	0.075%
5/5/2021	Los Angeles Capital Management LLC	18,005	$0.51M	0.0%	-42.0%	0.064%
5/5/2021	Natixis Advisors L.P.	12,130	$0.34M	0.0%	+18.7%	0.043%
5/4/2021	Symons Capital Management Inc.	8,055	$0.23M	0.1%	N/A	0.029%
5/4/2021	Victory Capital Management Inc.	18,079	$0.51M	0.0%	-4.3%	0.064%
5/3/2021	The Manufacturers Life Insurance Company	15,045	$0.42M	0.0%	-5.3%	0.053%
4/28/2021	US Bancorp DE	5,443	$0.15M	0.0%	-67.1%	0.019%
4/5/2021	Pacer Advisors Inc.	2,572	$72K	0.0%	-39.3%	0.009%
3/9/2021	tru Independence LLC	700	$18.20M	0.0%	N/A	0.003%
3/9/2021	Amundi Pioneer Asset Management Inc.	379,326	$9.86M	0.0%	+8.6%	1.357%
3/8/2021	B. Metzler seel. Sohn & Co. Holding AG	12,019	$0.34M	0.0%	N/A	0.043%
3/2/2021	Norges Bank	267,560	$6.96M	0.0%	N/A	0.958%
2/25/2021	Hsbc Holdings PLC	13,268	$0.35M	0.0%	+41.5%	0.048%
2/24/2021	EMC Capital Management	14,197	$0.37M	0.3%	N/A	0.051%
2/19/2021	JPMorgan Chase & Co.	131,330	$3.42M	0.0%	-1.7%	0.471%
2/19/2021	AtonRa Partners	16,139	$0.42M	0.2%	N/A	0.058%
2/17/2021	Voloridge Investment Management LLC	49,643	$1.29M	0.0%	N/A	0.178%
2/17/2021	Cetera Advisor Networks LLC	10,350	$0.27M	0.0%	-4.6%	0.037%
2/16/2021	Squarepoint Ops LLC	15,109	$0.39M	0.0%	N/A	0.054%
2/16/2021	Glenmede Trust Co. NA	8,071	$0.21M	0.0%	-33.8%	0.029%
2/16/2021	Morgan Stanley	235,411	$6.12M	0.0%	+575.7%	0.844%
2/16/2021	Endurant Capital Management LP	207,293	$5.39M	1.9%	+52.5%	0.744%
2/16/2021	Tudor Investment Corp Et Al	38,780	$1.01M	0.0%	+314.4%	0.139%
2/16/2021	Nuveen Asset Management LLC	118,215	$3.07M	0.0%	-6.4%	0.424%
2/16/2021	Price T Rowe Associates Inc. MD	10,066	$0.26M	0.0%	-23.5%	0.036%
2/16/2021	Amundi Pioneer Asset Management Inc.	379,326	$9.86M	0.0%	+8.6%	1.361%
2/16/2021	Hood River Capital Management LLC	310,070	$8.06M	0.3%	+18.8%	1.112%
2/16/2021	Engineers Gate Manager LP	32,713	$0.85M	0.0%	N/A	0.117%
2/16/2021	Charles Schwab Investment Management Inc.	181,288	$4.71M	0.0%	+1.8%	0.650%
2/13/2021	American International Group Inc.	15,049	$0.39M	0.0%	-2.8%	0.054%
2/12/2021	DCF Advisers LLC	38,500	$1M	0.4%	-31.9%	0.138%
2/12/2021	Bamco Inc. NY	373,500	$9.71M	0.0%	+12.0%	1.340%
2/12/2021	Public Employees Retirement System of Ohio	55,338	$1.44M	0.0%	+39.1%	0.199%
2/12/2021	The Manufacturers Life Insurance Company	15,894	$0.41M	0.0%	+4.6%	0.057%
2/12/2021	Credit Suisse AG	82,451	$2.14M	0.0%	-91.7%	0.296%
2/12/2021	Virtus ETF Advisers LLC	20,576	$0.54M	0.2%	+53.1%	0.074%
2/11/2021	Northern Trust Corp	325,244	$8.46M	0.0%	-3.8%	1.167%
2/11/2021	Barclays PLC	55,625	$1.45M	0.0%	+369.0%	0.200%
2/11/2021	Steward Partners Investment Advisory LLC	1,100	$29K	0.0%	-43.6%	0.004%
2/10/2021	Rhumbline Advisers	34,947	$0.91M	0.0%	+2.8%	0.125%
2/9/2021	Wells Fargo & Company MN	59,990	$1.56M	0.0%	-5.8%	0.215%
2/9/2021	Bank of New York Mellon Corp	118,017	$3.07M	0.0%	-13.3%	0.423%
2/9/2021	ProShare Advisors LLC	10,035	$0.26M	0.0%	+31.1%	0.036%
2/8/2021	State Board of Administration of Florida Retirement System	13,930	$0.36M	0.0%	-4.6%	0.050%
2/8/2021	New York State Common Retirement Fund	60,271	$1.57M	0.0%	-11.5%	0.216%
2/8/2021	Russell Investments Group Ltd.	44,064	$1.15M	0.0%	-43.1%	0.158%
2/5/2021	BlackRock Inc.	2,064,205	$53.67M	0.0%	+1.9%	7.405%
2/5/2021	SG Americas Securities LLC	15,549	$0.40M	0.0%	-34.7%	0.056%
2/5/2021	US Bancorp DE	16,566	$0.43M	0.0%	-25.0%	0.059%

Data available starting January 2016

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Today's Range

Now: $25.74

$25.49

$26.77

50 Day Range

MA: $23.98

$19.40

$28.69

52 Week Range

Now: $25.74

$18.01

$53.73

Volume

601,942 shs

Average Volume

765,230 shs

Market Capitalization

$725.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2

Who are the company insiders with the largest holdings of Esperion Therapeutics?

Esperion Therapeutics' top insider investors include:

Target N V Biotech (Major Shareholder)
Timothy M Mayleben (CEO)

Who are the major institutional investors of Esperion Therapeutics?

Esperion Therapeutics' top institutional shareholders include:

Wasatch Advisors Inc. — 14.61%
Bellevue Group AG — 14.15%
BlackRock Inc. — 7.61%
Platinum Investment Management Ltd. — 5.68%
Point72 Asset Management L.P. — 2.30%
Pentwater Capital Management LP — 2.16%

Which major investors are selling Esperion Therapeutics stock?

During the last quarter, ESPR stock was sold by these institutional investors:

Bellevue Group AG
Nomura Holdings Inc.
Endurant Capital Management LP
Morgan Stanley
Goldman Sachs Group Inc.
Pinnacle Associates Ltd.
Hamilton Lane Advisors LLC
DCF Advisers LLC

Which major investors are buying Esperion Therapeutics stock?

During the last quarter, ESPR stock was bought by institutional investors including:

Point72 Asset Management L.P.
Citigroup Inc.
Wasatch Advisors Inc.
Pentwater Capital Management LP
Nuveen Asset Management LLC
BlackRock Inc.
Rafferty Asset Management LLC
GAM Holding AG

During the last year, these company insiders have bought Esperion Therapeutics stock:

Target N V Biotech (Major Shareholder)
Timothy M Mayleben (CEO)

Ultra-Low-Priced Lithium Stock Offers Unlimited Upside in Global EV Boom

From Resource Stock Digest | Ad

Details Here.